Braveheart Bio, Inc.
BRVE- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0002131524
In the last 90 days, Braveheart Bio, Inc. insiders filed 9 open-market purchases and 0 sales; no institution reported holding it in 13F filings for Q2 2026; no superinvestor holds it.
Superinvestors holding BRVE, Q2 2026
No superinvestor reported holding BRVE in Q2 2026.